Author: Sheryl L Chow, Biykem Bozkurt, William L Baker, Barry E Bleske, Khadijah Breathett, Gregg C Fonarow, Barry Greenberg, Prateeti Khazanie, Jacinthe Leclerc, Alanna A Morris, Nosheen Reza, Clyde W Yancy, American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing
Date published: 2022 Dec 8
Other: Special Notes: doi: 10.1161/CIR.0000000000001110. , Word Count: 141
Complementary and alternative medicines (CAM) are commonly used across the world by diverse populations and ethnicities but remain largely unregulated. Although many CAM agents are purported to be efficacious and safe by the public, clinical evidence supporting the use of CAM in heart failure remains limited and controversial. Furthermore, health care professionals rarely inquire or document use of CAM as part of the medical record, and patients infrequently disclose their use without further prompting. The goal of this scientific statement is to summarize published efficacy and safety data for CAM and adjunctive interventional wellness approaches in heart failure. Furthermore, other important considerations such as adverse effects and drug interactions that could influence the safety of patients with heart failure are reviewed and discussed.
Keywords: AHA Scientific Statements; coenzyme Q10; complementary therapies; dietary supplements; heart failure; tai chi; yoga.
PMID: 36475715 DOI: 10.1161/CIR.0000000000001110